(Q34160734)

31 July 2017

title

Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects (English)

1 reference

31 July 2017

0 references

0 references

Adamo Valle

1

0 references

Jordi Oliver

Jordi Oliver

11

0 references

Pilar Roca

Pilar Roca

10

0 references

Amaia Rodríguez

Amaia Rodríguez

3

0 references

Javier Gómez-Ambrosi

Javier Gómez-Ambrosi

9

0 references

Fernando Rotellar

Fernando Rotellar

4

0 references

author name string

Victoria Catalán

2

1 reference

31 July 2017

Victor Valentí

5

1 reference

31 July 2017

Camilo Silva

6

1 reference

31 July 2017

Javier Salvador

7

1 reference

31 July 2017

Gma Frühbeck

8

1 reference

31 July 2017

publication date

19 February 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

951-961

1 reference

The causes, prevalence, and treatment of obesity revisited in 2009: what have we learned so far?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Adipose proteome analysis: focus on mediators of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Inflammatory mediators of hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Non-alcoholic fatty liver disease proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Air displacement plethysmography: validation in overweight and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Pathology of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Hyperglycemia-induced mitochondrial alterations in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Dietary fructose and metabolic syndrome and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Proteomic analysis of fructose-induced fatty liver in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Proteomic changes associated with diabetes in the BB-DP rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

NASH: a mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

S-Adenosylmethionine: a control switch that regulates liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Prohibitin is expressed in pancreatic beta-cells and protects against oxidative and proapoptotic effects of ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Adipocyte triglyceride lipase expression in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

All-trans retinoic acid lowers serum retinol-binding protein 4 concentrations and increases insulin sensitivity in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2012.02765.X

10.1111/J.1478-3231.2012.02765.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference